Answer
The licence is mutation-specific, so validated testing is needed to confirm that the tumour carries the target alteration.
Sources for this answer
- AYVAKYT 300 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.